<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741172/" ref="ordinalpos=541&amp;ncbi_uid=5200789&amp;link_uid=PMC3741172" image-link="/pmc/articles/PMC3741172/figure/pone-0072297-g006/" class="imagepopup">Figure 6. Schematic model of the impaired Reelin <span class="highlight" style="background-color:">signaling</span> in AD..  From: Beta-Amyloid Impairs Reelin <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">β-Amyloid triggers changes in Reelin glycosylation impairing its ability to form active covalent homodimers. Accordingly, altered Reelin complexes display a reduced efficiency to bind the ApoER2 receptor, fail to induce efficient tyrosine phosphorylation of Dab1, and to transduce the signaling pathway that modulates tau phosphorylation by inhibition of GSK3β. Soluble Aβ can also contribute to the impaired ability of Reelin to activate its signaling cascade. An imbalance in 14-3-3 levels is also triggered by the inefficient Reelin signaling.</div></div>